Search

everythinglearnresearchcommunity

for

Search:↓

Mice without the Sp6 gene have problems developing several body parts, including hair, teeth, limbs, and lungs.

Finasteride effectively treats male hair loss, improving growth and density.

Two specific hair keratin genes are active during hair growth and decline as hair transitions to rest.

Skin organoids are a promising new model for studying human skin development and testing treatments.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Human placenta hydrogel helps restore cells needed for hair growth.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Stress activates a special function of the Vitamin D receptor with the help of c-Jun, which can also prevent cell death.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Some families have a genetic condition where they are born with irregular scalp defects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Obesity and lifestyle strongly affect heart aging.

The KRTAP15-1 gene affects cashmere fiber thickness in goats.

The Ovol2-Zeb1 circuit is crucial for skin healing and hair growth by guiding cell movement and growth.

Blocking certain fat production can reverse skin inflammation and hair loss.

Nanoencapsulation creates adjustable cell clusters for hair growth.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.